Clinical trial
A Prospective Randomised Study to Evaluate the Effect of Triggering Ovulation With GnRHa (Buserelin) and Low Dose hCG (Pregnyl) as Compared to the Use of Conventional Doses of hCG (Pregnyl)
NCT00627406 is registered in ClinicalTrials.gov with Regionshospitalet Viborg, Skive as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomised Study to Evaluate the Effect of Triggering Ovulation With GnRHa (Buserelin) and Low Dose hCG (Pregnyl) as Compared to the Use of Conventional Doses of hCG (Pregnyl)
- Lead sponsor
- Regionshospitalet Viborg, Skive
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- December 31, 2011
- Enrollment
- 384 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ohss (ovarian hyperstimulation)